NEW YORK (GenomeWeb News) – Australian molecular diagnostics firm Genetic Technologies today announced plans to raise about US$9.6 million.

The fund raising will take place in three tranches and net proceeds will be used to expand US distribution of GTG's BrevaGen breast cancer test, and to complete additional studies to add new ethnic groups — Hispanic- and African-Americans — in order to expand the test's addressable market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.